Serostim

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Serostim (recombinant DNA somatropin) is Serono's brand name prescription drug form of synthetic growth hormone, marketed for HIV-associated wasting.[1]

In December 2007, the U.S. District Court of Massachusetts - in a class-action lawsuit that involved Merck Serono and Serostim - fined Serono a total of $704 million in criminal and civil liabilities for enacting "illegal schemes to promote, market and sell its drug."[2]

References[edit]

  1. ^ http://www.serostim.com/
  2. ^ "SERONO TO PAY $704 MILLION FOR THE ILLEGAL MARKETING OF AIDS DRUG". Department of Justice. 17 October 2005. Retrieved 23 June 2018.

External links[edit]

http://www.serostimsettlement.com